4.6 Review

Obesity and Clonal Hematopoiesis of Indeterminate Potential: Allies in Cardiovascular Diseases and Malignancies

期刊

LIFE-BASEL
卷 13, 期 6, 页码 -

出版社

MDPI
DOI: 10.3390/life13061365

关键词

obesity; clonal hematopoiesis of indeterminate potential; CHIP; cardiovascular disease; malignancy; leukemia

向作者/读者索取更多资源

The clonal hematopoiesis of indeterminate potential (CHIP) refers to the presence of detectable somatic mutations in genes associated with hematologic cancers in individuals without any apparent evidence of such conditions. Studies have shown that the frequently altered genes in CHIP are also associated with an increased risk of cardiovascular diseases, type 2 diabetes mellitus, myeloid malignancies, and obesity. The shared pathogenetic mechanisms of obesity and CHIP contribute to the development of these conditions.
The clonal hematopoiesis of indeterminate potential (CHIP) is a term used to describe individuals who have detectable somatic mutations in genes commonly found in individuals with hematologic cancers but without any apparent evidence of such conditions. The mortality rate in individuals with CHIP is remarkably higher than the influence ascribed to hematologic malignancies, and it is plausible that cardiovascular diseases (CVD) could elucidate the apparent disparity. Studies have shown that the most frequently altered genes in CHIP are associated with the increased incidence of CVDs, type 2 diabetes mellitus (T2DM) and myeloid malignancies, as well as obesity. Additionally, multiple research studies have confirmed that obesity is also independently associated with these conditions, particularly the development and progression of atherosclerotic CVD. Considering the shared pathogenetic mechanisms of obesity and CHIP, our objective in this review was to investigate both preclinical and clinical evidence regarding the correlation between obesity and CHIP and the resulting implications of this interaction on the pathophysiology of CVDs and malignancies. The pro-inflammatory condition induced by obesity and CHIP enhances the probability of developing both diseases and increases the likelihood of developing CVDs, T2DM and malignancies, suggesting that a dangerous vicious loop may exist. However, it is vital to conduct additional research that will suggest targeted treatment options for obese individuals with CHIP in order to reduce harmful effects connected to these conditions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据